Concord Biotech Q1 Results

  • BSE: 543960
  • NSE: CONCORDBIO
  • ISIN: INE338H01029
  • Sector: -
BSE
1,842.55-11.05 (-0.60%)
Volume8.43 K
Updated: Fri 6 Sep, 2024 | 15:29:12
NSE
1,835.9-17.80 (-0.96%)
Volume2.64 L
Updated: Fri 6 Sep, 2024 | 15:40:52
Today: 1,824.10
1,910.35
52-Wk: 952.05
1,910.35

Q1 Results Highlights

  • Total Income
    ₹215.80 Cr.
    (10.77%)
  • Operating Profit
    ₹68.10 Cr.
    (15.21%)
  • Profit After Tax
    ₹59.59 Cr.
    (9.36%)
  • Operating Margin
    31.56%
    (4.01%)
Note: Comparison is on YoY basis

Quarterly - Concord Biotech Q1 Results

*All figures in crores except per share values
Fiscal PeriodJun 24Mar 23QoQ CompJun 23YoY Comp
Total Revenue 215.80853.17-32.34%194.8310.77%
Selling/ General/ Admin Expenses Total 31.66110.28-6.75%28.2512.07%
Depreciation/ Amortization 13.1854.03-3.93%13.041.05%
Other Operating Expenses Total 54.56219.39-11.83%54.020.99%
Total Operating Expense 147.70563.91-25.55%135.728.83%
Operating Income 68.10289.26-43.52%59.1115.21%
Net Income Before Taxes 79.52322.01-38.22%71.0411.95%
Net Income 59.59240.09-37.28%54.499.36%
Diluted Normalized EPS 5.7022.95-37.23%5.219.43%

Recommended For You

    More Recommendations

    Trending Stocks

      Subscribe to Our Newsletter

      Get daily newsletters around different themes from livemint.

      Subscribe
      HomeMarketsPremiumInstant LoanMint Shorts
        翻译: